tZERO Group, Inc., a blockchain-powered multi-asset infrastructure innovator, announced an enhancement to its proposal to convert TZROP security tokens into tokenized Series B preferred stock. The revised plan, announced on April 16, 2026, adds eight shares of tZERO common stock per TZROP share, alongside the previously proposed three shares of Series B preferred stock. This change follows feedback from investors seeking broader participation in the company's capital structure.
The resulting common shares are expected to be fully tokenized and held on-chain within tZERO's regulated wallet infrastructure. While the value depends on future business developments, dilution from financing rounds, and potential liquidity events, the goal is to provide enhanced exposure to another layer of tZERO's capital structure. Bed Bath & Beyond, Inc., tZERO's largest shareholder, expressed support for the proposal, including the significant dilution to its common stock position, subject to corporate governance enhancements. These include a designated Board seat for Bed Bath & Beyond and engaging Alvarez & Marsal for a comprehensive operational review.
Marcus Lemonis, Executive Chairman and CEO of Bed Bath & Beyond, stated, 'tZERO was born out of Beyond's vision for tokenization in financial services. We support the enhancements, particularly the addition of meaningful common equity for all TZROP holders, which we believe creates a more balanced and aligned structure.' Upon closing, tZERO CEO Alan Konevsky will become Chairman, succeeding Matt Mosman, who will continue as a director. Konevsky said, 'This revised proposal reflects feedback from our investor community, who expressed a strong desire for additional participation across our capital stack.'
Under the enhanced terms, existing TZROP holders will hold approximately 31% of both the outstanding Series B preferred stock and the common stock (including restricted stock units). The proposal reduces current common stockholders' interests by about 30% in that class and Series B holders' interests by 27%. On a fully diluted basis, TZROP holders would represent about 31% of the company, though their share at any exit event will depend on future factors.
tZERO engaged Dahn Consulting Group to analyze the relative value of TZROP, Series B preferred, and common stock. The report, available on the TZROP Amendment webpage here, indicates each Series A Preferred share is equivalent to approximately 1.13 Series B preferred shares or 2.76 common shares. The company does not intend to provide near-term liquidity for the tokenized common shares, unlike the Series B shares.
An updated pro forma capitalization table and FAQs are available on the same webpage. The restructuring remains subject to approval by required security holders and other conditions. Bed Bath & Beyond has indicated its intention to lead up to $10 million in additional capital through a convertible note financing, with terms summarized in the Consent Solicitation Statement dated April 7, 2026, available here.
